Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McMullen officially becomes new Agilent CEO

This article was originally published in Clinica

Executive Summary

Mike McMullen has become the new CEO of Agilent Technologies, replacing Bill Sullivan, who will be a company advisor until he retires at the end of October. New leader Mr McMullen was previously president and chief operating officer of the company, and has spent over 30 years with Agilent and Hewlett-Packard (which the former spun off from in 1999). Bio-analytical measurement specialist Agilent has been through a transitional period, announcing in September 2013 that it was splitting into two companies: one focused on life sciences and diagnostics, and the other on its electronic measurement (EM) business. It spun off the EM franchise, Keysight Technologies, in November 2014, after announcing in September that Mr Sullivan would retire from the new-look Agilent, and Mr McMullen take up the reins.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel